Advertisement

Topics

bluebird bio, TC BioPharm to develop Gamma Delta CAR T cell product candidates for cancer immunotherapy

02:58 EST 8 Dec 2017 | Pharmaceutical Business Review

bluebird bio and Scottish immunotherapy company TC BioPharm have partnered and signed a license agreement on gamma delta CAR T cells.

Original Article: bluebird bio, TC BioPharm to develop Gamma Delta CAR T cell product candidates for cancer immunotherapy

NEXT ARTICLE

More From BioPortfolio on "bluebird bio, TC BioPharm to develop Gamma Delta CAR T cell product candidates for cancer immunotherapy"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...